Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2

被引:0
|
作者
Liu, Hongwei [1 ]
Brostoff, Terza [1 ]
Ramirez, Ana [1 ]
Wong, Talia [1 ]
Rowland, Douglas J. [2 ]
Heffner, Mollie [3 ]
Flores, Arturo [1 ]
Willis, Brandon [3 ]
Evans, Jeffrey J. [3 ]
Lanoue, Louise [3 ]
Lloyd, K. C. Kent [3 ,4 ]
Coffey, Lark L. [1 ]
机构
[1] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA
[2] Univ Calif Davis, Coll Engn, Ctr Mol & Genom Imaging, Davis, CA USA
[3] Univ Calif Davis, Mouse Biol Program, Davis, CA USA
[4] Univ Calif Davis, Sch Med, Dept Surg, Davis, CA USA
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; mouse ACE2; mouse TMPRSS2; knock-in mouse; COVID-19; virus; pathogenesis; pulmonary function; EXPRESSION; COVID-19;
D O I
10.3389/fimmu.2024.1428711
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite a substantial body of research, we lack fundamental understanding of the pathophysiology of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) including pulmonary and cardiovascular outcomes, in part due to limitations of murine models. Most models use transgenic mice (K18) that express the human (h) angiotensin converting enzyme 2 (ACE2), ACE2 knock-in (KI) mice, or mouse-adapted strains of SARS-CoV-2. Further, many SARS-CoV-2 variants produce fatal neurologic disease in K18 mice and most murine studies focus only on acute disease in the first 14 days post inoculation (dpi). To better enable understanding of both acute (<14 dpi) and post-acute (>14 dpi) infection phases, we describe the development and characterization of a novel non-lethal KI mouse that expresses both the ACE2 and transmembrane serine protease 2 (TMPRSS2) genes (hACE2/hTMPRSS2). The human genes were engineered to replace the orthologous mouse gene loci but remain under control of their respective murine promoters, resulting in expression of ACE2 and TMPRSS2 instead of their murine counterparts. After intranasal inoculation with an omicron strain of SARS-CoV-2, hACE2/hTMPRSS2 KI mice transiently lost weight but recovered by 7 dpi. Infectious SARS-CoV-2 was detected in nasopharyngeal swabs 1-2 dpi and in lung tissues 2-6 dpi, peaking 4 dpi. These outcomes were similar to those in K18 mice that were inoculated in parallel. To determine the extent to which hACE2/hTMPRSS2 KI mice are suitable to model pulmonary and cardiovascular outcomes, physiological assessments measuring locomotion, behavior and reflexes, biomonitoring to measure cardiac activity and respiration, and micro computed tomography to assess lung function were conducted frequently to 6 months post inoculation. Male but not female SARS-CoV-2 inoculated hACE2/hTMPRSS2 KI mice showed a transient reduction in locomotion compared to control saline treated mice. No significant changes in respiration, oxygen saturation, heart rate variability, or conductivity were detected in SARS-CoV-2 inoculated mice of either sex. When re-inoculated 6 months after the first inoculation, hACE2/hTMPRSS2 KI became re-infected with disease signs similar to after the first inoculation. Together these data show that a newly generated hACE2/hTMPRSS2 KI mouse can be used to study mild COVID-19.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Structure adaptation in Omicron SARS-CoV-2/ hACE2: Biophysical origins of evolutionary driving forces
    Hsiao, Ya-Wen
    Bray, David J.
    Taddese, Tseden
    Jimenez-Serratos, Guadalupe
    Crain, Jason
    BIOPHYSICAL JOURNAL, 2023, 122 (20) : 4057 - 4067
  • [42] Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
    Carossino, Mariano
    Kenney, Devin
    O'Connell, Aoife K.
    Montanaro, Paige
    Tseng, Anna E.
    Gertje, Hans P.
    Grosz, Kyle A.
    Ericsson, Maria
    Huber, Bertrand R.
    Kurnick, Susanna A.
    Subramaniam, Saravanan
    Kirkland, Thomas A.
    Walker, Joel R.
    Francis, Kevin P.
    Klose, Alexander D.
    Paragas, Neal
    Bosmann, Markus
    Saeed, Mohsan
    Balasuriya, Udeni B. R.
    Douam, Florian
    Crossland, Nicholas A.
    VIRUSES-BASEL, 2022, 14 (03):
  • [43] Unbinding of hACE2 and inhibitors from the receptor binding domain of SARS-CoV-2 spike protein
    Mishra, Lokpati
    Bandyopadhyay, Tusar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (08): : 3245 - 3264
  • [44] Functionalized protein microparticles targeting hACE2 as a novel preventive strategy for SARS-CoV-2 infection
    Li, Yujia
    Huang, Yike
    Zhu, Kehui
    Duan, Xiaoqiong
    Li, Shilin
    Xu, Min
    Yang, Chunhui
    Liu, Jiaxin
    Baeumler, Hans
    Yu, Pin
    Xie, He
    Li, Bin
    Cao, Ye
    Chen, Limin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 638
  • [45] Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
    Katzman, Chaja
    Israely, Tomer
    Melamed, Sharon
    Politi, Boaz
    Sittner, Assa
    Yahalom-Ronen, Yfat
    Weiss, Shay
    Abu Rass, Reem
    Zamostiano, Rachel
    Bacharach, Eran
    Ehrlich, Marcelo
    Paran, Nir
    Nissim, Lior
    VIRUSES-BASEL, 2022, 14 (01):
  • [46] AAV6-Mediated hACE2 Expression as a Versatile Model for SARS-CoV-2 Infection and synDNA Vaccine Efficacy
    Gary, Ebony N.
    Warner, Bryce
    Parzych, Elizabeth
    Griffin, Bryan
    Zhu, Xizhou
    Tailor, NIkesh
    Chan, Mable
    Vandramelli, Robert
    Tursi, Nicholas J.
    Purwar, Mansi
    Reuschel, Emma
    Liaw, Kevin
    Ali, Ali
    Wootton, Sarah K.
    Patel, Ami
    Ramos, Stephanie
    Smith, Trevor
    Weiner, David B.
    Kobasa, Darwyn
    MOLECULAR THERAPY, 2021, 29 (04) : 363 - 363
  • [47] SARS-CoV-2 infection induces thymic atrophy mediated by IFN-γ in hACE2 transgenic mice
    Rizvi, Zaigham Abbas
    Sadhu, Srikanth
    Dandotiya, Jyotsna
    Sharma, Puja
    Binayke, Akshay
    Singh, Virendra
    Das, Vinayaka
    Khatri, Ritika
    Kumar, Rajesh
    Samal, Sweety
    Kalia, Manjula
    Awasthi, Amit
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (07)
  • [48] Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion
    Xu, Juan
    Yang, WenTao
    Pan, YiFeng
    Xu, HaiShun
    He, Liang
    Zheng, BingSong
    Xie, YingQiu
    Wu, XueQian
    FOOD AND CHEMICAL TOXICOLOGY, 2022, 169
  • [49] Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2
    Zhao, Min
    Su, Pei-Yi
    Castro, Danielle A.
    Tripler, Therese N.
    Hu, Yingxia
    Cook, Matthew
    Ko, Albert, I
    Farhadian, Shelli F.
    Israelow, Benjamin
    Dela Cruz, Charles S.
    Xiong, Yong
    Sutton, Richard E.
    PLOS PATHOGENS, 2021, 17 (06)
  • [50] SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
    Fricke, Charlie
    Pfaff, Florian
    Ulrich, Lorenz
    Halwe, Nico Joel
    Schoen, Jacob
    Timm, Laura
    Hoffmann, Weda
    Rauch, Susanne
    Petsch, Benjamin
    Hoffmann, Donata
    Beer, Martin
    Corleis, Bjoern
    Dorhoi, Anca
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 (12)